205 related articles for article (PubMed ID: 28053055)
21. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG;
Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986
[TBL] [Abstract][Full Text] [Related]
22. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
23. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.
Tan MC; Mansour N; White DL; Sisson A; El-Serag HB; Thrift AP
Aliment Pharmacol Ther; 2020 Jul; 52(1):20-36. PubMed ID: 32452599
[TBL] [Abstract][Full Text] [Related]
24. Review article: Barrett's oesophagus and carcinoma in Japan.
Hongo M
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
[TBL] [Abstract][Full Text] [Related]
25. Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus.
Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
Aliment Pharmacol Ther; 2016 Oct; 44(8):775-84. PubMed ID: 27562355
[TBL] [Abstract][Full Text] [Related]
26. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies?
Kunzmann AT; Coleman HG; Johnston BT; Turkington RC; McManus D; Anderson LA; Thrift AP
Dig Dis Sci; 2021 Jun; 66(6):1965-1973. PubMed ID: 32734400
[TBL] [Abstract][Full Text] [Related]
27. Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population-based nationwide cohort study.
Erichsen R; Horvath-Puho E; Lund JL; Dellon ES; Shaheen NJ; Pedersen L; Davey Smith G; Sørensen HT
Aliment Pharmacol Ther; 2017 Apr; 45(7):973-982. PubMed ID: 28139003
[TBL] [Abstract][Full Text] [Related]
28. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
Murphy SJ; Anderson LA; Mainie I; Fitzpatrick DA; Johnston BT; Watson RG; Gavin AT; Murray LJ
Scand J Gastroenterol; 2005 Dec; 40(12):1449-53. PubMed ID: 16316894
[TBL] [Abstract][Full Text] [Related]
29. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
Moghissi K; Sharpe DA; Pender D
Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
[TBL] [Abstract][Full Text] [Related]
30. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Scand J Gastroenterol; 2004 Jul; 39(7):680-5. PubMed ID: 15370691
[TBL] [Abstract][Full Text] [Related]
31. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.
Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS
Gastroenterology; 2013 Aug; 145(2):312-9.e1. PubMed ID: 23673354
[TBL] [Abstract][Full Text] [Related]
32. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Tan MC; El-Serag HB; Yu X; Thrift AP
Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
[TBL] [Abstract][Full Text] [Related]
33. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
Reid BJ; Li X; Galipeau PC; Vaughan TL
Nat Rev Cancer; 2010 Feb; 10(2):87-101. PubMed ID: 20094044
[TBL] [Abstract][Full Text] [Related]
34. Barrett's oesophagus: frequency and prediction of dysplasia and cancer.
Falk GW
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):125-38. PubMed ID: 25743461
[TBL] [Abstract][Full Text] [Related]
35. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II).
Ruol A; Merigliano S; Baldan N; Santi S; Petrin GF; Bonavina L; Ancona E; Peracchia A
Dis Esophagus; 1997 Jul; 10(3):190-5. PubMed ID: 9280078
[TBL] [Abstract][Full Text] [Related]
36. Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia.
Ye W; Nyrén O
Gut; 2003 Jul; 52(7):938-41. PubMed ID: 12801947
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and regional variations of patients with Barrett's oesophagus in the UK.
Caygill CP; Watson A; Reed PI; Hill MJ;
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1217-22. PubMed ID: 14560156
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and risk factors for oesophageal adenocarcinoma.
Lepage C; Drouillard A; Jouve JL; Faivre J
Dig Liver Dis; 2013 Aug; 45(8):625-9. PubMed ID: 23453359
[TBL] [Abstract][Full Text] [Related]
39. External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia.
Kunzmann AT; Thrift AP; Johnston BT; McManus DT; Gavin AT; Turkington RC; Coleman HG
Aliment Pharmacol Ther; 2019 May; 49(10):1274-1281. PubMed ID: 30950101
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
